RIPE-KG · Version 1.1.0 · Resource

ripekg:study-design-evidence/RIPEA44677276976C010D

https://w3id.org/ripe/ripe-kg/study-design-evidence/RIPEA44677276976C010D
SubjectPredicateObject
ripekg:evaluation/RIPEA44677276976C010D prov:used ripekg:study-design-evidence/RIPEA44677276976C010D
ripekg:study-design-evidence/RIPEA44677276976C010D rdf:type rdfs:Resource
ripekg:study-design-evidence/RIPEA44677276976C010D rdf:type owl:Thing
ripekg:study-design-evidence/RIPEA44677276976C010D rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:study-design-evidence/RIPEA44677276976C010D rdf:type ripe:StudyDesignEvidenceStudy design evidence
ripekg:study-design-evidence/RIPEA44677276976C010D rdf:type tido:Evidence
ripekg:study-design-evidence/RIPEA44677276976C010D prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA44677276976C010D
ripekg:study-design-evidence/RIPEA44677276976C010D prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA44677276976C010D
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:concerns ripekg:work/10.1136%2Fbmj-2024-083382Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8)
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:concerns ripekg:work/10.1136%2Fbmj-2024-083382e083382 | the bmj Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:recruitmentEndDate 11-2022
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:recruitmentEndDateExtractionRationale Methods: 'November 2022' is the end date for when the trial was conducted, but it is not a recruitment end date.
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:recruitmentStartDate 09-2021
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:recruitmentStartDateExtractionRationale Methods: 'September 2021' is the start date for when the trial was conducted.
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:studyEndDate 10-2024
ripekg:study-design-evidence/RIPEA44677276976C010D ripe:studyEndDateExtractionRationale Methods: 'October 2024' is the end date for when the trial was conducted.
ripekg:study-design-evidence/RIPEA44677276976C010D tido:supports ripekg:integrity-assessment-hypothesis/RIPEA44677276976C010D-human-2-2
ripekg:study-design-evidence/RIPEA44677276976C010D tido:supports ripekg:integrity-assessment-hypothesis/RIPEA44677276976C010D-inspectai-2-2